Clinical Trials Browser

Phase 2 × Keratosis, Actinic × Papillomavirus Vaccines × Clear all

NCT05202860 2025-01-22

VAXAK

Phase 2 Active not recruiting

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Keratosis, Actinic